Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Relmada Therapeutics, Inc. | RLMD | 49.2K | $340.48K |
Zymeworks Inc. | ZYME | 50.83K | $1.33M |
Aura Biosciences, Inc. | AURA | 51.05K | $362.42K |
Denali Therapeutics Inc. | DNLI | 53.69K | $1.38M |
ACADIA Pharmaceuticals Inc. | ACAD | 55.14K | $1.4M |
Wave Life Sciences Ltd. | WVE | 55.74K | $323.86K |
PennantPark Floating Rate Capital Ltd. | PFLT | 58.93K | $440.83K |
Syndax Pharmaceuticals, Inc. | SNDX | 63.72K | $1.39M |
New Mountain Finance Corporation | NMFC | 67.25K | $482.21K |
Goldman Sachs BDC, Inc. | GSBD | 67.75K | $642.24K |
Theravance Biopharma Inc | TBPH | 69.89K | $1.19M |
Aurinia Pharmaceuticals Inc. | AUPH | 73.51K | $1.25M |
FS KKR Capital Corp. | FSK | 74.75K | $784.82K |
Devon Energy Corporation | DVN | 74.86K | $3.09M |
Sarepta Therapeutics, Inc. | SRPT | 75.96K | $1.36M |
Arbutus Biopharma Corp | ABUS | 76.81K | $368.67K |
Atai Beckley Inc. | ATAI | 83.47K | $439.88K |
Companhia Energética de Minas Gerais | CIG | 93.87K | $197.13K |
FS Credit Opportunities Corp. | FSCO | 96K | $479.06K |
Recursion Pharmaceuticals, Inc. | RXRX | 103.87K | $381.21K |